34 results were returned
The French Health Data Hub was born officially with the publication on 30 November 2019 of a ministerial decision (arrêté).
Biotech and medtech companies operate in an international environment where the composition of their governance bodies is a key criterion of credibility.
In the last five decades we have been assisting on the digitalization of society and consequently of the healthcare sector; we have been using terms such as eHealth, medical informatics, health informatics, ...
The world's most popular banana is dying. Scientists are using the gene-editing mechanism CRISPR to try and save it from extinction.
A majority postulates a new "outward presentation test" to deal with the infringement of second medical use patents.
On 26 August 2019, China's National People's Congress passed the final amendments to the Drug Administration Law ("DAL"), which will take effect on 1 December 2019. The DAL was first enacted in 1984, then substantively ...
On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").
So notes the Commission's report on competition enforcement in the pharmaceutical sector (2009-2017) published at the end of January 2019.
Following seminal “denigration” cases from the French, Danish and Italian competition authorities, our competition team looks into this new practice of exclusionary abuse.
Today in Actavis v ICOS the Supreme Court unanimously ruled that the ICOS patent for a Tadalafil dosing regime was invalid. Lord Hodge gave the only judgment, with Lady Hale, Lord Kerr, Lord Sumption and Lord Briggs in ...